Curcumin and muscle wasting-A new role for an old drug?

被引:53
作者
Alamdari, Nima [1 ]
O'Neal, Patrick [1 ]
Hasselgren, Per-Olof [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Muscle atrophy; Proteolysis; Nuclear factor-kappa B; Catabolic; NF-KAPPA-B; SKELETAL-MUSCLE; UBIQUITIN LIGASES; GENE-EXPRESSION; UP-REGULATION; ACTIVATION; CACHEXIA; SEPSIS; GROWTH; BURN;
D O I
10.1016/j.nut.2008.09.002
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Sepsis, severe injury, and cancer are associated with loss of muscle mass. Muscle wasting in these conditions is mainly caused by increased proteolysis, at least in part regulated by nuclear factor-kappa B. Despite recent progress in the understanding of mediators and mechanisms involved in muscle wasting, effective and universally accepted treatments by which muscle atrophy can be prevented or reversed are still lacking. We review recent evidence suggesting that curcumin (diferuloylmethane), a component of the spice turmeric, may prevent loss of muscle mass during sepsis and endotoxemia and may stimulate muscle regeneration after traumatic injury. Curcumin has been part of the traditional Asian medicine for centuries, mainly because of its anti-inflammatory properties. Studies suggest that inhibition of nuclear factor-kappa B is one of the mechanisms by which curcumin exerts its ant-inflammatory effects. Curcumin is easily accessible, inexpensive, and non-toxic even at high doses, and may therefore offer an important treatment modality in muscle wasting and injury. It should be noted, however, that the muscle-sparing effects of curcumin are not universally accepted, and more studies are therefore needed to further test the role of curcumin in the prevention and treatment of muscle wasting. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 43 条
[21]   Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation [J].
Hasselgren, PO ;
Fischer, JE .
ANNALS OF SURGERY, 2001, 233 (01) :9-17
[22]   Muscle protein catabolism after severe burn: Effects of IGF-1/IGFBP-3 treatment [J].
Herndon, DN ;
Ramzy, PI ;
DebRoy, MA ;
Zheng, M ;
Ferrando, AA ;
Chinkes, DL ;
Barret, JP ;
Wolfe, RR ;
Wolf, SE .
ANNALS OF SURGERY, 1999, 229 (05) :713-722
[23]   Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss [J].
Jin, Bingwen ;
Li, Yi-Ping .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (04) :960-969
[24]  
Jobin C, 1999, J IMMUNOL, V163, P3474
[25]   Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials [J].
Kley, R. A. ;
Tarnopolsky, M. A. ;
Vorgerd, M. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (04) :366-367
[26]   Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products [J].
Ladner, KJ ;
Caliguri, MA ;
Guttridge, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) :2294-2303
[27]   Regulation of muscle protein synthesis during sepsis and inflammation [J].
Lang, Charles H. ;
Frost, Robert A. ;
Vary, Thomas C. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (02) :E453-E459
[28]   Dose escalation of a curcuminoid formulation [J].
Christopher D Lao ;
Mack T Ruffin ;
Daniel Normolle ;
Dennis D Heath ;
Sandra I Murray ;
Joanne M Bailey ;
Martha E Boggs ;
James Crowell ;
Cheryl L Rock ;
Dean E Brenner .
BMC Complementary and Alternative Medicine, 6 (1)
[29]   Protein degradation by the ubiquitin-proteasome pathway in normal and disease states [J].
Lecker, Stewart H. ;
Goldberg, Alfred L. ;
Mitch, William E. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07) :1807-1819
[30]   NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes [J].
Li, YP ;
Reid, MB .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (04) :R1165-R1170